rifamycin-sv has been researched along with Tuberculosis--Pulmonary* in 25 studies
25 other study(ies) available for rifamycin-sv and Tuberculosis--Pulmonary
| Article | Year |
|---|---|
No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
Rifabutin has been substituted for rifampicin when treating tuberculosis (TB)/HIV coinfection. However, despite reports of anti-TB treatment failure and acquired rifamycin resistance, long-term clinical outcome data are lacking. Observational analyses performed in a UK TB/HIV cohort demonstrated no difference in severe adverse events, anti-TB treatment completion, relapse frequency or subsequent rifamycin resistance when rifampicin and rifabutin were compared, using different combinations of antiretroviral therapy. Our data support the wider use of rifabutin in TB/HIV coinfection. Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Coinfection; Drug Resistance, Bacterial; Female; HIV Infections; Humans; Male; Retrospective Studies; Rifabutin; Rifamycins; Treatment Outcome; Tuberculosis, Pulmonary | 2013 |
[USE AND ACTION OF THE NEW ANTIBIOTIC RIFAMYCIN SV (RIFOCIN)].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Pneumonectomy; Rifamycins; Staphylococcal Infections; Surgical Wound Infection; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1965 |
[CONTRIBUTION TO THE STUDY OF THE GENERAL AND LOCAL THERAPY OF PULMONARY AND PLEURAL TUBERCULOSIS WITH RIFAMYCIN SV (RIFOCINE)].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 1965 |
[RESEARCH ON THE BEHAVIOR OF TUBERCULIN ALLERGY DURING TREATMENT WITH RIFAMYCIN SV].
Topics: Animals; Biomedical Research; Guinea Pigs; Hypersensitivity; Isoniazid; Pharmacology; Research; Rifamycins; Tuberculin; Tuberculin Test; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[LOCAL USE OF "RIFAMYCIN-SV"(RF-SV) IN PULMONARY TUBERCULOSIS].
Topics: Bronchial Fistula; Drug Resistance; Drug Resistance, Microbial; Empyema; Empyema, Tuberculous; Pharmacology; Rifamycins; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabolism; Cycloserine; Diabetes Mellitus; Drug Tolerance; Ethionamide; Humans; Isoniazid; Kanamycin; Pharmacology; Pyrazinamide; Rifamycins; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[FIRST EXPERIENCES IN THE USE OF RIFAMYCIN SV ASSOCIATED WITH PAS USING THE METHOD OF VENOUS PERFUSION. CLINICAL CONTRIBUTION].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Humans; Infusions, Parenteral; Isoniazid; Radiography, Thoracic; Rifamycins; Streptomycin; Tomography; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[CLINICAL TOLERANCE OF RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION. (RESEARCH ON THE USE OF SOLUTIONS CONTAINING OR WITHOUT POLYVINYLPYRROLIDONE AND ON THE ASSOCIATION WITH PARA-AMINOSALYCILIC ACID)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Therapy; Drug Tolerance; Infusions, Parenteral; Povidone; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[Rifamycin SV in endocavitary aspiration].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Rifamycin SV in treatment by endobronchial route of pulmonary tuberculosis].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Local application of rifamycin SV in caverns treated by endocavitary aspiration].
Topics: Caves; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Clinical contribution to the treatment of pulmonary tuberculosis with rifamycin SV].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Tolerance and activity of venous perfusions of rifamycin SV in the treatment of human tuberculosis].
Topics: Drug Tolerance; Infusions, Parenteral; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Rifamycin SV in the local treatment of pulmonary tuberculosis].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Topical antitubercular action of rifamycin SV].
Topics: Antitubercular Agents; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Findings on the endocavitary use of rifamycin SV].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[Experiences with rifamycin SV administered endobronchially].
Topics: Bronchiectasis; Bronchitis; Lung Abscess; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[RIFOMYCIN. (A NEW ANTIBIOTIC)].
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Dermatology; Metabolism; Pharmacology; Rifamycins; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[RIFOMYCIN SV IN LABORATORY TESTS].
Topics: Drug Tolerance; Guinea Pigs; Metabolism; Mycobacterium tuberculosis; Pharmacology; Research; Rifamycins; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[DIFFUSION FACTORS AND ANTITUBERCULOUS CHEMOTHERAPY. (1ST CLINICAL RESULTS OF A SPECIAL METHOD OF ANTIBIOTIC ADMINISTRATION)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Glycoside Hydrolases; Hyaluronoglucosaminidase; Rifamycins; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[LOCAL USE OF RIFOMYCIN-SV (RF-SV) IN PULMONARY TUBERCULOSIS. PRELIMINARY COMMUNICATION].
Topics: Bronchial Fistula; Drug Resistance; Drug Resistance, Microbial; Empyema; Empyema, Tuberculous; Pharmacology; Rifamycins; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[1st clinical observations in the tuberculosis field with rifamycin SV administered by venous perfusion].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary; Veins | 1962 |
[Rifomycin SV in intracavitary aspiration].
Topics: Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1962 |
[Rifomycin SV in clinical practice. Preliminary data on its therapeutic value in the tubercular field].
Topics: Anti-Bacterial Agents; Rifamycins; Tuberculosis; Tuberculosis, Pulmonary | 1961 |